GNLY Antikörper (PE)
-
- Target Alle GNLY Antikörper anzeigen
- GNLY (Granulysin (GNLY))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser GNLY Antikörper ist konjugiert mit PE
-
Applikation
- Flow Cytometry (FACS), Immunoprecipitation (IP)
- Aufreinigung
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.
- Klon
- DH2
- Isotyp
- IgG1 kappa
- Top Product
- Discover our top product GNLY Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Protect from prolonged exposure to light. Do not freeze.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- The antibody solution should be stored undiluted between 2°C and 8°C.
-
- Target
- GNLY (Granulysin (GNLY))
- Andere Bezeichnung
- Granulysin (GNLY Produkte)
- Synonyme
- 519 antikoerper, D2S69E antikoerper, LAG-2 antikoerper, LAG2 antikoerper, NKG5 antikoerper, TLA519 antikoerper, granulysin antikoerper, GNLY antikoerper
- Hintergrund
- Granulysin is a member of the saposin-like protein family of lipid binding proteins (SAPLIP). It is expressed by NK cells and cytolytic T lymphocytes (CTL) as 9 kD and 15 kD forms. The 9 kD form is derived from the 15 kD form by cleavage at both amino- and carboxy-termini. Granulysin has broad cytolytic activities against a variety of tumor cells and microbes, including Gram-positive and -negative bacteria, fungi and parasites. It also functions as a chemoattractant for inflammatory cells and activates the cells expression of cytokines and chemokines.
-